Alnara Pharmaceuticals Inc.
Funding rounds
1 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jan 2010 | $20 M | No. 1 | $10 to $50 million | equity | SEC |
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Alnara Pharmaceuticals Inc. chose not to state its revenue in its newest notice of a funding round (Feb 2010).
SEC Form D · Feb 2010
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Feb 2010
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Alnara Pharmaceuticals Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Alexey Margolin | Executive officer | Feb 2010 |
| Lee Brettman | Executive officer | Feb 2010 |
| Robert Gallotto | Executive officer | Feb 2010 |
| Alexey Margolin | Director | Feb 2010 |
| Ashley H. Dombkowski | Director | Feb 2010 |
| Christoph H. Westphal | Director | Feb 2010 |
| James N. Topper | Director | Feb 2010 |
| Richard H. Aldrich | Director | Feb 2010 |
| Robert H. Tepper | Director | Feb 2010 |